Taysha Gene Therapies Inc (TSHA) operating margin is -9.3%
Taysha Gene Therapies Inc (TSHA) operating margin is -9.3% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full TSHA research page for quote, filings, and the rest of the model. This satellite exists so “Taysha Gene Therapies Inc operating margin” can rank with the actual number, then send you to /stock/tsha.